| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/25/2004 | CN1477968A Methods for treating rheumatic diseases using soluble CTLA4 molecule |
| 02/25/2004 | CN1477193A Novel human Rab GTP enzyme, its coding sequence and application |
| 02/25/2004 | CN1477129A Recombinant vascular endothelial growth factor-diphtherin fusion protein, its preparation and application |
| 02/25/2004 | CN1477125A A polypeptide-human amelification protein 23 and polynucleotide for coding said polypeptide |
| 02/25/2004 | CN1477124A A polypeptide-zinc finger protein 42 and polynucleotide for coding said polypeptide |
| 02/25/2004 | CN1477123A A polypeptide-transcription factor 43 and polynucleotide coding said polypeptide |
| 02/25/2004 | CN1477122A A polypeptide-human blood vessel epithelial calcium adhesion protein 54 and polynuceotide for coding said polypeptide |
| 02/25/2004 | CN1477121A A polypeptide-human ankyrin 27 and polynucleotide coding said polypeptide |
| 02/25/2004 | CN1477120A A polypeptide-human tissue anion transport polypeptide 41 and polynucleotide coding said polypeptide |
| 02/25/2004 | CN1477119A Novel Human cysteine proteinase inhibitor sample molecule, its coding sequence and application |
| 02/25/2004 | CN1477118A Novel DnaJ/Hsp40 molecule DC-DJIII, its coding sequence and application |
| 02/25/2004 | CN1477117A Novel human phosphotidylethanolamine binding protein, its coding sequence and application |
| 02/25/2004 | CN1477116A Novel human secretion-related membrane protion, its coding sequence and its application |
| 02/25/2004 | CN1477115A Novel human cyclin, its coding sequence and application |
| 02/25/2004 | CN1477114A Immunoglobulin sample receptor originated from human dendritic cell, its coding sequence and application |
| 02/25/2004 | CN1477113A Recombinant human fatty acid oxidation protein, its production method and application |
| 02/24/2004 | US6696620 Immunoglobulin binding protein arrays in eukaryotic cells |
| 02/24/2004 | US6696557 Isolated nucleic acid comprising nucleotide sequence encoding extracellular domain of al-2 fused to immunoglobulin amino acid sequence |
| 02/24/2004 | US6696547 Mutant DEDD proteins for regulating apoptosis |
| 02/24/2004 | US6696412 Purification of daptomycin by binding to ion exchange resins in the presence of buffers and chaotropic agents, then eluting and recovering; peptide antibiotics |
| 02/24/2004 | US6696303 Inhibition of amyloid protein bnding to neuronal receptor; obtain cell, incubate with modulator, monitor amyloid protein activity |
| 02/24/2004 | US6696276 Vasopermeability-enhancing conjugates |
| 02/24/2004 | US6696275 Generating preferential polypeptide; obtain nucleotide sequences, mutate, express nucleotide sequences, separate and recover polypeptide |
| 02/24/2004 | US6696273 FEBP1 Protein: vector, host cells and method for making FEBP1 protein |
| 02/24/2004 | US6696263 PCNA associated cell cycle proteins, compositions and methods of use |
| 02/24/2004 | US6696245 Methods for selecting functional polypeptides |
| 02/24/2004 | US6696062 BASB006 polypeptides from Neisseria meningitidis and immunogenic compositions thereof |
| 02/24/2004 | US6696061 Binds human major histocompatibility complex (mhc) class ii allotype |
| 02/24/2004 | CA2219081C Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/24/2004 | CA2132213C Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
| 02/24/2004 | CA2102036C Vaccines raising an immunological response against the disease caused by the iowa strain of porcine reproductive and respiratory syndrome virus |
| 02/19/2004 | WO2004015391A2 Mass spectrometry-based identification of proteins |
| 02/19/2004 | WO2004015125A1 Process for preparing peptides with anti-hypertensive properties |
| 02/19/2004 | WO2004015124A1 Process for the production of a heterologous protein |
| 02/19/2004 | WO2004015118A1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 02/19/2004 | WO2004015109A1 Human acid sensing ion channel 2b (hasic2b), process for producing the same, and its use |
| 02/19/2004 | WO2004015059A2 Methods and compositions for in vitro synthesis of biological macromolecules in a cell-free system enriched with atp-sulfurylase |
| 02/19/2004 | WO2004015057A2 Mucin-immunoglobulin fusion proteins |
| 02/19/2004 | WO2004014311A2 Nogo receptor antagonists |
| 02/19/2004 | WO2003097834A3 A method for in vitro molecular evolution of protein function |
| 02/19/2004 | WO2003088979A3 Oligonucleotides from sequences coding for the surface component of envelope proteins of primate t-cell leukaemia/lymphoma viruses (ptlv) and uses thereof |
| 02/19/2004 | WO2003087318A3 Truncated 24 kda basic fibroblast growth factor |
| 02/19/2004 | WO2003085124A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/19/2004 | WO2003080640B1 Lymphatic and blood endothelial cell genes |
| 02/19/2004 | WO2003054172A3 Glutamine-auxothrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium |
| 02/19/2004 | WO2003050275A3 Method of isolation and purification of trypsin from pronase and use thereof |
| 02/19/2004 | WO2003050265A3 Compositions and methods for normalizing assays |
| 02/19/2004 | WO2003047756A3 Device and method for processing biological or chemical substances or substance mixtures thereof |
| 02/19/2004 | WO2003046571A3 Hp and apolipoprotein biopolymer markers predictive of alzheimers disease |
| 02/19/2004 | WO2003046564A3 Protein biopolymer markers predictive of alzheimers disease |
| 02/19/2004 | WO2003040341A3 Anti-hepatitis a virus antibodies |
| 02/19/2004 | WO2003031596A3 Production of a highly active, soluble form of the cytochrome p450 reductase (cpr a) from candida tropicalis |
| 02/19/2004 | WO2003008537A9 Epitope sequences |
| 02/19/2004 | WO2003000113A9 Compositions and methods for the diagnosis and treatment of tumor |
| 02/19/2004 | WO2002088185A3 Pan-specific monoclonal antibody |
| 02/19/2004 | WO2002083866A3 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 02/19/2004 | WO2002081496A3 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours |
| 02/19/2004 | WO2002076380A3 Cytotoxic factors for modulating cell death |
| 02/19/2004 | WO2002074251A3 Monoclonal antibody therapy for pancreas cancer |
| 02/19/2004 | WO2002072863A8 Methods for large scale protein matching |
| 02/19/2004 | WO2002061086A3 Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 02/19/2004 | WO2002048337A3 Secreted human proteins |
| 02/19/2004 | WO2002046477A3 Endogenous retroviruses up-regulated in prostate cancer |
| 02/19/2004 | WO2002028888A3 Mimotope of neisseria meningitides lipooligosaccharide and vaccines containing the same |
| 02/19/2004 | WO2001088190A3 Poly-primed amplification of nucleic acid sequences |
| 02/19/2004 | US20040034883 Fungl elicitor and process for its preparation |
| 02/19/2004 | US20040034197 Biosynthesizing trypsin and/or trypsinogen amino acid sequences, analogs and catalytic polypeptides with altered active sites and binding domains which recognize and bind to ester leaving groups |
| 02/19/2004 | US20040034195 Multimerized highly functional antifreeze protein |
| 02/19/2004 | US20040033978 Antisense oligonucleotides complementary to and that hybridize with RNA, used for gene expression inhibition, prophylaxis and medical diagnosis |
| 02/19/2004 | US20040033953 Cry proteins; endotoxins |
| 02/19/2004 | US20040033595 Conditionally replicating vectors for inhibiting viral infections |
| 02/19/2004 | US20040033577 Herbicides test method |
| 02/19/2004 | US20040033565 Isolated human G-Protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 02/19/2004 | US20040033564 Method for increasing solubility of target protein using RNA-binding protein as fusion partner |
| 02/19/2004 | US20040033560 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033559 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033558 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033542 Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer |
| 02/19/2004 | US20040033535 Antibodies to OPGL |
| 02/19/2004 | US20040033533 Method of diagnosing metabolic bone diseases |
| 02/19/2004 | US20040033527 Methods of using a three-dimensional model of a Fc epsilon receptor alpha chain |
| 02/19/2004 | US20040033514 Detection of disease related genes |
| 02/19/2004 | US20040033511 Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZEe (antibody-mediated apoptosis inducing cytokines) |
| 02/19/2004 | US20040033504 Novel compounds |
| 02/19/2004 | US20040033491 Proteins and nucleic acids encoding same |
| 02/19/2004 | US20040033487 Comprises nucleotide sequences coding associated with glycosylation of viral structural polypeptides; prototype immunogens for treatment and prevention of viral disease; genetic vaccines |
| 02/19/2004 | US20040033231 First domain comprising a PP14 polypeptide sequence and a second domain comprising a polypeptide sequence of the Fc region of an immunoglobulin protein; treatment of immune system diseases and disorders |
| 02/19/2004 | US20040033229 PSMA antibodies and protein multimers |
| 02/19/2004 | US20040033215 Transferring a cell proliferation factor gene into a mammalian liver cell, for an in vitro immortalized cell, proliferating the immortalized cell, and removing the cell proliferation factor gene |
| 02/19/2004 | DE10237082A1 Bioreactor producing cellular product receives feedstuffs from first and second feedstuff containers and discharges to a feedback arrangement |
| 02/19/2004 | CA2495121A1 Nogo receptor antagonists |
| 02/19/2004 | CA2493623A1 Methods and compositions for in vitro synthesis of biological macromolecules in a cell-free system enriched with atp-sulfurylase |
| 02/19/2004 | CA2489301A1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 02/18/2004 | EP1389239A2 Methods and compositions for making emamectin |
| 02/18/2004 | EP1389235A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 02/18/2004 | EP1389233A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 02/18/2004 | EP0817851B1 Dna encoding human papilloma virus type 18 |
| 02/18/2004 | EP0798376B1 Novel keratan sulfate hydrolase |
| 02/18/2004 | EP0734264B1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 02/18/2004 | EP0731838B1 Binding structures directed against the ca55.1 antigen |